Pharmacological Basis for Cladribine Resistance

References

• Fox, M., Boyle, J.M. and Kinsella, A.R. (1991) "Nucleoside salvage and resistance to antimetabolite anticancer agents", Br. J. Cancer 64(3), 428–436.
   Web of Science ®Google Scholar
• Mackey, J.R., Baldwin, S.A., Young, J.D. and Cass, C.E. (1998) The Role of Nucleoside Transport in Anticancer Drug Resistance. Drug Resistance Updates 1 (Churchill Livingstone, Edinburgh), pp 310–324.
   Google Scholar
• Carson, D.A., Wasson, D.B., Taetle, R. and Yu, A. (1983) "Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes", Blood 62(4), 737–743.
   PubMed Web of Science ®Google Scholar
• Beutler, E., Sipe, J., Romine, J., Mcmillan, R., Zyroff, J. and Koziol, J. (1996) "Treatment of multiple sclerosis and other autoimmune diseases with cladribine", Semin. Hematol.
   Google Scholar
• Bryson, H.M. and Sorkin, E.M. (1993) "Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies [Review]", Drugs 46(5), 872–894.
   Google Scholar
• Juliusson, G. and Liliemark, J. (1996) "Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in pre-viously treated patients with chronic lymphocytic leukemia", Ann. Oncol. 7(4), 373–379.
   Google Scholar
• Schirmer, M., Mur, E., Pfeiffer, KR, Thaler, J. and Konwalinka, G. (1997) "The safety profile of low-dose cladribine in refractory rheumatoid arthritis. A pilot trial", Scand. J. Rheumatol. 26(5), 376–379.
   Web of Science ®Google Scholar
• Sjoberg, AR, Wang, L. and Eriksson, S. (1998) "Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs", Mol. Phannacol. 53(2), 270–273.
   Google Scholar
• Eriksson, S., Kierdaszuk, B., Munch-Petersen, B., Oberg, B. and Johansson, N.G. (1991) "Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs", Biochem. Biophys. Res. Commun. 176(2), 586–592.
   Google Scholar
• Parker, W.B., Bapat, AR., Shen, J.X., Townsend, A.J. and Cheng, Y.C. (1988) "Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleo-tide reductase", Mol. Phannacol. 34(4), 485–491.
   Google Scholar
• Hentosh, P., Koob, R. and Blakley, R.L. (1990) "Incorporation of 2-halogeno-2'-deoxyadenosine 5-triphosphates into DNA during replication by human polymerases alpha and beta", J. Biol. Chem. 265(7), 4033–4040.
   Web of Science ®Google Scholar
• Hentosh, P. and Grippo, P. (1994) "Template of 2-chloro-2'-deoxyadenosine monophosphate inhibits in vitro DNA synthesis", Mol. PhannacoL 45(5), 955–961.
   Google Scholar
• Leoni, L.M., Chao, Q., Cottam, H.B., et al. (1998) "Induction of an apoptotic program in cell-free extracts by 2-chloro-2'-deoxyadeno-sine 5'-triphosphate and cytochrome c", Proc. Natl Acad. Sci. USA 95(16), 9567–9571.
   PubMed Web of Science ®Google Scholar
• Seto, S., Carrera, C.J., Kubota, M., Wasson, D.B. and Carson, D.A. (1985) "Mechanism of deoxyadenosine and 2-chlorodeoxyadeno-sine toxicity to nondividing human lymphocytes", J. Clin. Investig. 75(2), 377–383.
   Google Scholar
• Genini, D., Budihardjo, I., Plunkett, W., et al. (2000) "Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor- 1-mediated caspase pathway", J. Biol. Chem. 275(1), 29–34.
   Web of Science ®Google Scholar
• Golde, D.W., Jakubowiak, A., Caggiano, J. and Heaney, M.L. (2002) "Cladribine underdosing in hairy-cell leukemia: a cause for apparent response failure", Leuk. Lymphoma 43(2), 365–367.
   PubMed Web of Science ®Google Scholar
• Albertioni, F., Juliusson, G. and Liliemark, J. (1993) "On the bioavailability of 2-chloro-2'-deoxyadenosine (CdA). The influence of food and omeprazole", Eur. J. Clin. PhannacoL 44(6), 579–582.
   PubMed Web of Science ®Google Scholar
• Liliemark, J. and Juliusson, G. (1995) "Cellular pharmacokinetics of 2-chloro-2'-deoxyadenosine nucleotides: comparison of inter-mittent and continuous intravenous infusion and subcutaneous and oral administration in leukemia patients", Clin. Cancer Res. 1, 385–390.
   PubMed Web of Science ®Google Scholar
• Lindemalm, S., Larsson, B., Liliemark, J. and Albertioni, F. (1997) "Distribution of 2-chloro-2'-deoxyadenosine, 2-chloro- 2'-arabino-fluoro-2'-deoxyadenosine, fludarabine, cytarabine in mouse using whole-body autoradiography". Manuscript.
   Google Scholar
• Albertioni, F., Lindemalm, S., Reichelova, V, et al. (1998) "Pharmacokinetics of cladribine in plasma and its 5'-monophos-phate and 5'-triphosphate in leukemic cells of patients with chronic lymphocytic leukemia", Clin. Cancer Res. 4(3), 653–658.
   Web of Science ®Google Scholar
• Liliemark, J. and Juliusson, G. (1991) "On the pharmacokinetics of 2-chloro-2'-deoxyadenosine in humans", Cancer Res. 51(20), 5570–5572.
   PubMed Web of Science ®Google Scholar
• Albertioni, F., Pettersson, B., Reichelova, V, Juliusson, G. and Liliemark, J. (1994) "Analysis of 2-chloro-2'-deoxyadenosine in human blood plasma and by high-performance liquid chromato-graphy using solid-phase extraction", Ther. Drug Monit. 16(4), 413–418.
   PubMed Web of Science ®Google Scholar
• Carson, D.A., Wasson, D.B. and Yu, A. (1984) "Cell cycle independent lymphocytotoxicity of 2-chlorodeoxyadenosine", Adv. Exp. Med. Biol.
   Google Scholar
• Carson, D.A., Wasson, D.B. and Beutler, E. (1984) "Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine", Proc. Natl Acad. Sci. USA 81(7), 2232–2236.
   PubMed Web of Science ®Google Scholar
• Saven, A., Cheung, W.K., Smith, I., et al. (1996) "Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy", J. Clin. OncoL 14(3), 978–983.
   Web of Science ®Google Scholar
• Liliemark, J., Albertioni, F., Hassan, M. and Juliusson, G. (1992) "On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration", J. Clin. OncoL 10(10), 1514–1518.
   Web of Science ®Google Scholar
• Juliusson, G., Heldal, D., Hippe, E., et al. (1995) "Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia", J. Clin. OncoL 13(4), 989–995.
   Web of Science ®Google Scholar
• Von Rohr, A., Schmitz, S.F., Tichelli, A., et al. (2002) "Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study", Ann. OncoL 13(10), 1641–1649.
   Google Scholar
• Cass, CE., Young, J.D., Baldwin, S.A., et al. (1999) "Nucleoside transporters of mammalian cells", Phann. BiotechnoL 12, 313 —352.
   PubMedGoogle Scholar
• Lang, T.T., Selner, M., Young, J.D. and Cass, C.E. (2001) "Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyri-midine nucleosides in drug-resistant leukemia cells", Mol. PhannacoL 60(5), 1143–1152.
   Google Scholar
• Crawford, C.R., Ng, C.Y., Noel, L.D. and Belt, J.A. (1990) "Nucleoside transport in L1210 murine leukemia cells. Evidence for three transporters", J. Biol. Chem. 265(17), 9732–9736.
   Web of Science ®Google Scholar
• Gerstin, K.M., Dresser, M.J. and Giacomini, KM. (2002) "Specificity of human and rat orthologs of the concentrative nucleoside transporter, SPNT", Am. J. Physiol. Renal PhysioL 283(2), F344—F349.
   PubMed Web of Science ®Google Scholar
• White, J.C., Rathmell, J.P. and Capizzi, R.L. (1987) "Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells", J. Clin. Investig. 79(2), 380–387.
   Google Scholar
• Wright, AM., Gati, W.P. and Paterson, AR. (2000) "Enhancement of retention and cytotoxicity of 2-chlorodeoxyadenosine in cultured human leukemic lymphoblasts by nitrobenzylthioinosine, an inhibitor of equilibrative nucleoside transport", Leukemia 14(1), 52–60.
   PubMed Web of Science ®Google Scholar
• Gati, W.P., Paterson, A.R., Belch, A.R., et al. (1998) "Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC)", Leuk. Lymphoma 32(1-2), 45–54.
   PubMed Web of Science ®Google Scholar
• Beck, F.W., Al-Katib, A.M., Ahmad, I., et al. (2000) "Bryostatin 1-induced modulation of nucleoside transporters and 2-chloro-deoxyadenosine influx in WSU-CLL cells", Int. J. Mol. Med. 5(4), 341–347.
   PubMed Web of Science ®Google Scholar
• Jamieson, G.P., Brocklebank, A.M., Snook, M.B., et al. (1993) "Flow cytometric quantitation of nucleoside transporter sites on human leukemic cells", Cytometty 14(1), 32–38.
   PubMed Web of Science ®Google Scholar
• Wright, A.M., Paterson, A.R., Sowa, B., Akabutu, J.J., Grundy, P.E. and Gati, W.P. (2002) "Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content", Br J. HaematoL 116(3), 528–537.
   Web of Science ®Google Scholar
• Wang, L., Karlsson, A., Arner, ES. and Eriksson, S. (1993) "Substrate specificity of mitochondrial 2'-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine", J. Biol. Chem. 268(30), 22847–22852.
   Web of Science ®Google Scholar
• Avery, T.L., Rehg, J.E., Lumm, W.C., Harwood, F.C., Santana, V.M. and Blakley, R.L. (1989) "Biochemical pharmacology of 2-chlorodeoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxyadenosine in drug combinations in mice", Cancer Res. 49(18), 4972–4978.
   PubMed Web of Science ®Google Scholar
• Sasvari-Szekely, M., Spasokoukotskaja, T., Szoke, M., et al. (1998) "Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chlorodeoxy-2'-deoxyadenosine (Cladribine) in human lymphocytes", Biochem. Phannacol. 56(9), 1175–1179.
   PubMed Web of Science ®Google Scholar
• On, R.M., Talbot, D.C., Aheme, W.G., Fisher, T.C., Serafinowski, P. and Harrap, K.R. (1995) "2!-Deoxycytidine kinase deficiency is a major determinant of 2-chloro-2'-deoxyadenosine resistance in lymphoid cell lines In process citation]", Clin. Cancer Res. 1(4), 391–398.
   Web of Science ®Google Scholar
• Mansson, E., Spasokoukotskaja, T., Sallstrom, J., Eriksson, S. and Albertioni, F. (1999) "Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line", Cancer Res. 59(23), 5956–5963.
   PubMed Web of Science ®Google Scholar
• Dumontet, C., Fabianowska-Majewska, K., Mantincic, D., et al. (1999) "Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K362", Br J. HaematoL 106(1), 78–85.
   PubMed Web of Science ®Google Scholar
• Funato, T., Satou, J. and Nishiyama, Y. (2000) "In vitro leukemia cell models of Ara-C resistance", Leuk. Res. 24(6), 535–541.
   Google Scholar
• Lotfi, K., Mansson, E., Peterson, C., Eriksson, S. and Albertioni, F. (2002) "Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofosyl-guanine cytotoxicity", Biochem. Biophys. Res. Commun. 293(5), 1489–1496.
   Google Scholar
• Mansson, E., Flordal, E., Liliemark, J., et al. (2003) "Down-regulation of deoxycytidine kinase in leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance", Biochem. Phanna-col. 65(2), 237–247.
   Google Scholar
• Kawasaki, H., Carrera, C.J., Piro, L.D., Saven, A., Kipps, T.J. and Carson, D.A. (1993) "Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine", Blood 81(3), 597–601.
   PubMed Web of Science ®Google Scholar
• Arner, ES., Spasokoukotskaja, T., Juliusson, G., Liliemark, J. and Eriksson, S. (1994) "Phosphorylation of 2-chlorodeoxyadenosine (CdA) in extracts of peripheral blood mononuclear cells of leukaemic patients", Br J. Haematol. 87(4), 715–718.
   Web of Science ®Google Scholar
• Kakihara, T., Fukuda, T., Tanaka, A., et al. (1998) "Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: decreased expression of dCK gene in relapsed leukemia", Leuk. Lymphoma 31(3-4), 405–409.
   PubMed Web of Science ®Google Scholar
• Carson, DA., Carrera, C.J., Wasson, D.B. and lizasa, T. (1991) "Deoxyadenosine-resistant human T lymphoblasts with elevated 5'-nucleotidase activity", Biochim. Biophys. Acta 1091(1), 22–28.
   PubMed Web of Science ®Google Scholar
• Hunsucker, S.A., Spychala, J. and Mitchell, B.S. (2001) "Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance", J. Biol. Chem. 276(13), 10498–10504.
   Web of Science ®Google Scholar
• Schirmer, M., Stegmann, AR, Geisen, F. and Konwalinka, G. (1998) "Lack of cross-resistance with gemcitabine and cytarabine in cladribine- resistant HL60 cells with elevated 5'-nucleotidase activity", Exp. HematoL 26(13), 1223–1228.
   Web of Science ®Google Scholar
• Galmarini, C., Thomas, X., CaIvo, F., Rousselot, R, El Jaffari, A., Cross, E. and Dumontet, C. (2000) "Expression of cytoplasmic 5'-nucleotidase in leukemic blasts is an adverse prognostic factor in AML patients treated with cytarabine", ASH, 101a.
   Google Scholar
• Lotfi, K., Mansson, E. and Chandra, J. (2001) "Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide", Br. J. HaematoL 113(2), 339–346.
   Web of Science ®Google Scholar
• Mohammad, R.M., Beck, F.W., Katato, K., Hamdy, N., Wall, N. and Al-Katib, A. (1998) "Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): association with increased ratios of dCK/5'-NT and Bax/Bc1-2", Biol. Chem. 379(10), 1253–1261.
   Google Scholar
• Gazziola, C., Moras, M., Ferraro, P., et al. (1999) "Induction of human high K (M) 5'-nucleotidase in cultured 293 cells", Exp. Cell. Res. 253(2), 474–482.
   Web of Science ®Google Scholar
• Zhu, C., Johansson, M., Permert, J. and Karlsson, A. (1998) "Enhanced cytotoxicity of nucleoside analogs by overexpression of mitochondrial deoxyguanosine kinase in cancer cell lines", J. Biol. Chem. 273(24), 14707–14711.
   Web of Science ®Google Scholar
• Hentosh, P. and Tibudan, M. (1997) "2-Chloro-2'-deoxyadenosine, an antileukemic drug, has an early effect on cellular mitochondrial function", MoL PhannacoL 51(4), 613–619.
   PubMed Web of Science ®Google Scholar
• Owens, J.K., Shewach, D.S., Ullman, B. and Mitchell, B.S. (1992) "Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene", Cancer Res. 52(9), 2389–2393.
   PubMed Web of Science ®Google Scholar
• Flasshove, M., Strumberg, D., Ayscue, L, et al. (1994) "Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside", Leukemia 8(5), 780–785.
   PubMed Web of Science ®Google Scholar
• Veuger, M.J., Honders, MW., Landegent, J.E., Willemze, R. and Barge, R.M. (2000) "High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia", Blood 96(4), 1517–1524.
   PubMed Web of Science ®Google Scholar
• Leegwater, RA., De Abreu, R.A. and Albertioni, F. (1998) "Analysis of DNA methylation of the region of the deoxycytidine kinase gene in CCRF-CEM-sensitive and cladribine (CdA)-and 2-chloro-2'-arabino-ffuoro-2'-deoxyadenosine (CAFdA)-resistant cells", Cancer Lett. 130(1–2), 169–173.
   Google Scholar
• Griffig, J., Koob, R. and Blaldey, R.L. (1989) "Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells", Cancer Res.
   Google Scholar
• Hirota, Y., Yoshioka, A., Tanaka, S., et al. (1989) "Imbalance of deoxyribonucleoside triphosphates, DNA double-strand breaks, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cells", Cancer Res. 49(4), 915–919.
   PubMed Web of Science ®Google Scholar
• Choy, BK., McClarty, GA., Chan, AK., Thelander, L. and Wright, J.A. (1988) "Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations", Cancer Res. 48(8), 2029–2035.
   PubMed Web of Science ®Google Scholar
• Goan, Y.G., Thou, B., Hu, E., Mi, S. and Yen, Y. (1999) "Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2-difluorodeoxycytidine in the human KB cancer cell line", Cancer Res. 59(17), 4204–4207.
   PubMed Web of Science ®Google Scholar
• Jordan, A. and Reichard, P. (1998) "Ribonucleotide reductases", Annu. Rev. Biochem. 67, 71–98.
   PubMed Web of Science ®Google Scholar
• Cardoen, S., Van Den Neste, E., Snal, C., et al. (2001) "Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB", Clin. Cancer Res. 7(11), 3559–3566.
   Web of Science ®Google Scholar
• Hickman, J.A., Potten, CS., Merritt, A.J. and Fisher, T.C. (1994) "Apoptosis and cancer chemotherapy", Philos. Trans. R. Soc. Lond. B Biol. Sci. 345(1313), 319–325.
   Google Scholar
• Slee, E.A., Adrain, C. and Martin, S.J. (1999) "Serial killers: ordering caspase activation events in apoptosis", Cell. Death Differ 6(11), 1067–1074.
   PubMed Web of Science ®Google Scholar
• Golstein, P. (1997) "Cell death: TRAIL and its receptors", Curr. Biol. 7(12), R750—R753.
   Google Scholar
• Li, P., Nijhawan, D., Budihardjo, I., et al. (1997) "Cytochrome c and dATP-dependent formation Apaf-l/caspase-9 complex initiates initiates an apoptotic protease cascade", Cell 91(4), 479–489.
   Google Scholar
• Sun, X.M., MacFarlane, M., Zhuang, J., Wolf, B.B., Green, D.R. and Cohen, G.M. (1999) "Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis", J. Biol. Chem. 274(8), 5053–5060.
   Web of Science ®Google Scholar
• Kaufmann, S.H. and Earnshaw, W.C. (2000) "Induction of apoptosis by cancer chemotherapy", Exp. Cell. Res. 256(1), 42–49.
   Web of Science ®Google Scholar
• Marzo, I., Perez-Galan, P., Giraldo, P., Rubio-Felix, D., Anel, A. and Naval, J. (2001) "Cladribine induces apoptosis in human leukaemia cells by caspase-dependent and -independent pathways acting on mitochondria", Biochem. J. 359\(Pt 3), 537–546.
   PubMed Web of Science ®Google Scholar
• Perez-Galan, P., Marzo, I., Giraldo, P., et al. (2002) "Role of caspases and apoptosis-inducing factor (AIF) in cladribine-induced apoptosis of B cell chronic lymphocytic leukemia", Leukemia 16(10), 2106–2114.
   PubMed Web of Science ®Google Scholar
• Nomura, Y., Inanami, 0., Takahashi, K., Matsuda, A. and Kuwabara, M. (2000) "2-chloro-2'-deoxyadenosine induces apop-tosis through the FasFas ligand pathway in human leukemia cell line MOLT-4", Leukemia 14(2), 299–306.
   Google Scholar
• Genini, D., Adachi, S., Chao, Q., et al. (2000) "Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria", Blood 96(10), 3537–3543.
   PubMed Web of Science ®Google Scholar
• Pettitt, A.R., Clarke, A.R., Cawley, J.C. and Griffiths, S.D. (1999) "Purine analogues kill resting lymphocytes by p53-dependent and -independent mechanisms", Br. J. HaematoL 105(4), 986–988.
   Web of Science ®Google Scholar
• Galmarini, C.M., Voorzanger, N., Falette, N., et al. (2003) "Influence of p53 and p21 (WAF1) expression on sensitivity of cancer cells to cladribine", Biochem. PhannacoL 65(1), 121–129.
   PubMed Web of Science ®Google Scholar
• Chandra, J., Mansson, E., Gogvadze, V., Kaufmann, S.H., Albertioni, F. and Orrenius, S. (2002) "Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release", Blood 99(2), 655–663.
   PubMed Web of Science ®Google Scholar
• McGahon, A.J., Costa Pereira, AR, Daly, L. and Cotter, T.G. (1998) "Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system", Br J. HaematoL 101(3), 539–547.
   Web of Science ®Google Scholar
• Richardson, D.S., Allen, RD., Kelsey, S.M. and Newland, A.C. (1999) "Inhibition of FAS/FAS-ligand does not block chemothe-rapy-induced apoptosis in drug sensitive and resistant cells", Adv. Exp. Med. Biol. 457, 259–266.
   PubMed Web of Science ®Google Scholar
• Bosanquet, A.G., Sturm, I., Wieder, T., et al. (2002) "Box expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia", Leukemia 16(6), 1035–1044.
   PubMed Web of Science ®Google Scholar
• Saven, A., Lemon, R.H. and Piro, L.D. (1993) "2-Chlorodeoxy-adenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine [letter; comment]", N. Engl. J. Med. 328(11), 812–813.
   Google Scholar
• O'Brien, S., Kantarjian, H., Estey, E., et al. (1994) "Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy [see comments]", N. Engl. J. Med. 330(5), 319–322.
   Google Scholar
• Juliusson, G., Elmhorn, R.A. and Liliemark, J. (1992) "Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lympho-cytic leukemia resistant to fludarabine [see comments]", N. EngL J. Med. 327(15), 1056–1061.
   Web of Science ®Google Scholar
• Rondelli, D., Lauria, F., Zinzani, P.L., et al. (1997) "2-Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders", Eur J. Haematol. 58(1), 46–50.
   Google Scholar
• Fukuda, T., Kamishima, T., Kakihara, T., Ohnishi, Y. and Suzuki, T. (1996) "Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines", Leuk. Res. 20(11-12), 931–939.
   Google Scholar
• Grant, S., Turner, A., Nelms, P. and Yanovich, S. (1995) "Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1 beta-D-arabinofuranosylcytosine", Leukemia 9(5), 808–814.
   PubMed Web of Science ®Google Scholar
• Mansson, E., Paul, A., Lofgren, C., et al. (2001) "Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance doxorubicin: implications for combination chemotherapy", Br J. Haematol. 114(3), 557–565.
   Web of Science ®Google Scholar
• Higashigawa, M., Ido, M., Nagao, Y, et al. (1991) "Decreased DNA polymerase sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine", Leuk. Res. 15(8), 675–681.
   Google Scholar
• Tanaka, M. and Yoshida, S. (1982) "Altered sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate of DNA polymerase alpha from leukemic blasts of acute lymphoblastic leukemia", Cancer Res. 42(2), 649–653.
   PubMed Web of Science ®Google Scholar
• Manome, Y, Wen, P.Y., Dong, Y, et al. (1996) "Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo", Nat. Med. 2(5), 567–573.
   Web of Science ®Google Scholar
• Kojima, H., lida, M., Miyazaki, H., Koga, T., Moriyama, H. and Manome, Y. (2002) "Enhancement of cytarabine sensitivity in squamous cell carcinoma cell line transfected with deoxycytidine kinase", Arch. Otolaryngol. Head Neck Surg. 128(6), 708–713.
   Web of Science ®Google Scholar
• Zheng, X., Johansson, M. and Karlsson, A. (2000) "Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase", J. Biol. Chem. 275(50), 39125–39129.
   Web of Science ®Google Scholar
• Munch-Petersen, B., Knecht, W., Lenz, C., Sondergaard, L. and Piskur, J. (2000) "Functional expression of a multisubstrate deoxyribonucleoside kinase from Drosophila melanogaster and its C-terminal deletion mutants", J. Biol. Chem. 275(9), 6673–6679.
   Web of Science ®Google Scholar
• Rose, J.D., Parker, W.B., Someya, H., Shaddix, S.C., Montgomery, J.A. and Secrist, LA., BI (2002) "Enhancement of nucleoside cytotoxicity through nucleotide prodrugs", J. Med. Chem. 45(20), 4505–4512.
   Web of Science ®Google Scholar
• Hapke, D.M., Stegmann, A. and Mitchell, B.S. (1996) "Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity", Cancer Research 56(10), 2343–2347.
   PubMed Web of Science ®Google Scholar
• Lotfi, K., Mansson, E., Spasokoukotskaja, T., et al. (1999) "Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2i-deoxyadenosine, a novel analogue of cladri-bine in human leukemic cells", Clin. Cancer Res. 5(9), 2438–2444.
   Web of Science ®Google Scholar